Canine Ovarian Remnant Syndrome Study Guide

Overview and Clinical Importance

Ovarian remnant syndrome (ORS) is defined as the presence of functional ovarian tissue in a previously ovariohysterectomized (spayed) bitch. This condition results from incomplete removal of one or both ovaries during the original spay procedure, leading to continued production of reproductive hormones and recurrence of estrus signs. ORS is an important differential diagnosis when a spayed female dog presents with signs of heat and represents a recognized complication of ovariohysterectomy (OHE) and ovariectomy (OVE).

The condition is clinically significant because untreated ORS can lead to serious complications including uterine stump pyometra, mammary neoplasia, and ovarian tumors (particularly granulosa cell tumors). Understanding ORS is essential for NAVLE success as it tests knowledge of reproductive physiology, diagnostic endocrinology, and surgical principles.

Etiology and Pathophysiology

Causes of Ovarian Remnant Syndrome

There are three primary mechanisms by which ovarian tissue may remain after spaying:

• Incomplete surgical removal (most common): Improper placement of clamps or ligatures, poor visualization of the surgical field, or failure to exteriorize the entire ovary. The right ovary is affected more frequently than the left due to its anatomical position.
• Dropped ovarian tissue: A fragment of ovarian cortex becomes detached during surgical manipulation and falls into the abdominal cavity where it may revascularize and become functional again (autotransplantation).
• Ectopic ovarian tissue: Congenital presence of functional ovarian tissue in an abnormal location such as the ovarian ligament or abdominal wall. Note: True ectopic ovaries have NOT been reported in dogs; accessory ovaries are only documented in cats, cows, and humans.

Incidence and Risk Factors

Reported incidence rates of ORS range from 0.1% to 0.5% of all ovariohysterectomy procedures. In one review of OHE complications, ORS accounted for 17% of all complications encountered. Importantly, studies have found no association between ORS and difficult ovariohysterectomies (such as in overweight or deep-chested dogs), pyometra, or surgeon experience level.

Summary: Etiology of Ovarian Remnant Syndrome

Review: Normal Canine Estrous Cycle

Understanding the normal canine estrous cycle is essential for recognizing ORS. The bitch is monoestrous (one estrus per cycle) and non-seasonally polyestrous (cycles year-round). Dogs typically cycle every 5-11 months (average 6-7 months). The cycle consists of four phases:

Clinical Presentation

Clinical signs of ORS mimic those of a normal estrous cycle because the remnant tissue produces the same hormones as an intact ovary. Signs typically appear months to years after the original spay (median 17 months, range 1 month to 10 years). Notably, dogs with neoplastic changes in the remnant may have a longer interval to symptom onset (median 96 months).

Signs of Proestrus/Estrus

• Vulvar swelling: Firm, edematous vulva typical of proestrus
• Vaginal discharge: Serosanguinous (bloody) in proestrus, may become straw-colored in estrus
• Behavioral changes: Restlessness, increased activity, flagging behavior, may allow mounting
• Attractiveness to males: Male dogs show interest due to pheromone production
• Mammary gland development: May occur, especially with pseudopregnancy following the heat cycle

Important Clinical Features

• Signs are CYCLICAL, occurring every 5-11 months (normal interestrous interval)
• Affected dogs may allow mating but CANNOT become pregnant (no uterus if OHE performed)
• Signs may be subtle - some owners mistake them for urinary incontinence or behavioral issues
• Pseudopregnancy (enlarged mammary glands, nesting behavior) may follow the heat cycle

Differential Diagnosis

Before diagnosing ORS, other causes of estrogen exposure must be ruled out:

Diagnostic Approach

A systematic diagnostic approach is essential for confirming ORS before surgical intervention. The diagnosis relies on demonstrating the presence of functional ovarian tissue through hormonal testing, vaginal cytology, and/or imaging.

Vaginal Cytology

Vaginal cytology is a rapid, inexpensive first-line test that serves as a bioassay for estrogen. In ORS, cytology findings reflect the stage of the estrous cycle produced by the remnant tissue.

Vaginal Cytology Findings by Cycle Stage

Hormonal Testing

Hormonal assays are the gold standard for confirming ORS. The combination of anti-Mullerian hormone (AMH) and progesterone testing on a single serum sample is currently the most accurate diagnostic approach.

Hormone Stimulation Tests

When baseline hormone levels are inconclusive or the patient is not showing signs of estrus, stimulation tests can be performed:

• hCG Stimulation Test: 250 IU hCG subcutaneously induces ovulation if follicular tissue present. Measure progesterone 1-2 weeks later. Progesterone greater than 2 ng/mL confirms ORS.
• GnRH Stimulation Test: 2.2 mcg/kg GnRH IM or 25 mcg for cats. Measure progesterone 2-3 weeks later. GnRH is preferred over hCG due to lower risk of anaphylaxis.

Diagnostic Imaging

Abdominal Ultrasound: Can visualize cystic structures or hypoechoic masses in the region of the ovarian pedicles, especially if follicles or corpora lutea are present. Sensitivity is approximately 94% when performed by an experienced operator, though specificity is lower (74%). Ultrasound is most useful as an adjunct to hormonal testing and for surgical planning.

CT Scan: May be used to localize remnant tissue before surgery, particularly if the remnant is not in the expected location near the ovarian pedicles. Provides better anatomical detail than ultrasound.

Diagnostic Algorithm for ORS

• History: Spayed female dog with signs of heat (cyclical vulvar swelling, discharge, behavioral changes)
• Physical examination: Confirm vulvar swelling and rule out other causes of discharge
• Vaginal cytology: If greater than 80-90% cornified superficial cells = estrogen influence confirmed
• Hormonal testing: Submit combined AMH + Progesterone on single serum sample
• Abdominal ultrasound: Attempt to localize remnant and assess for stump pyometra
• Surgical exploration: Definitive diagnosis and treatment

Complications of Untreated ORS

If left untreated, ORS can lead to several serious complications due to continued hormone exposure:

Treatment

Surgical removal of remnant ovarian tissue is the treatment of choice and is curative in the vast majority of cases. Medical management is not recommended as a primary treatment because it does not eliminate the risks of complications.

Surgical Treatment

Timing of Surgery

Optimal timing is during estrus or 3-6 weeks after induced ovulation when the tissue is most vascularized and enlarged, making identification easier. The presence of follicles or corpora lutea increases the size of the remnant.

Surgical Approaches

Surgical Principles

• Examine BOTH ovarian pedicles regardless of preoperative imaging findings
• Most remnants are located at the ovarian pedicles; right side more common than left
• Adhesions are present in approximately 79% of cases and complicate surgical access
• Use bipolar vessel sealing device for tissue dissection and hemostasis
• If remnant cannot be identified, remove granulation tissue at each pedicle and ligate closer to aorta
• ALWAYS submit excised tissue for histopathology to confirm ovarian tissue and rule out neoplasia
• Assess uterine stump; if cystic endometrial hyperplasia or pyometra present, remove stump

Medical Management

Medical management is NOT recommended as primary treatment due to significant side effects and failure to address underlying tissue. However, it may be considered in patients who are poor surgical candidates:

• Megestrol acetate: Synthetic progestin that suppresses estrus. Side effects include increased risk of pyometra, diabetes mellitus, mammary hyperplasia, and adrenal suppression.
• Mibolerone: Androgenic steroid that prevents estrus. Side effects include hepatotoxicity, behavioral changes, and clitoral hypertrophy. Not currently available in many countries.

Prognosis

Excellent with complete surgical removal. Successful removal of the ovarian tissue is curative, and clinical signs resolve. Long-term follow-up studies show resolution of estrus signs in greater than 95% of cases. Confirm treatment success with:

• Resolution of clinical signs (no further heat cycles)
• Histopathology confirming ovarian tissue in excised specimen
• Follow-up hormone testing: GnRH stimulation test with progesterone or repeat AMH (should be negative)

Prevention

ORS is an iatrogenic condition that is preventable with proper surgical technique:

• Ensure adequate incision length for proper visualization
• Use good surgical lighting and adequate retraction
• Properly break down the suspensory ligament to exteriorize the ovary
• Place clamps and ligatures proximal to the ovary, ensuring complete removal
• Visually confirm both ovaries are completely removed before closing
• Handle ovarian tissue carefully to prevent fragmentation and dropped tissue